Brief: Senti Bio Reports Q4 Results
22/03/2023 21:10
March 22 (Reuters) - Senti Biosciences Inc SNTI.O :
* SENTI BIO REPORTS FOURTH QUARTER AND FULL YEAR 2022
FINANCIAL
RESULTS AND REVIEWS RECENT HIGHLIGHTS
Source text for Eikon: ID:nGNX9wW3Ym
Further company coverage: SNTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates